Connect with us

Trending

Heart Damage Found to Be More Common Following Moderna Vaccinations According to New Study Finds

Published

on

Researchers discovered that about 1 in 35 health care workers at a Swiss hospital who received the mRNA-1273 vaccine had signs of heart injury linked to it. Normally, this level would only be around 1 percent in a healthy population.

According to the study, which was published in the European Journal of Heart Failure, “mRNA-1273 booster vaccination-associated elevation of markers of myocardial injury occurred in about one out of 35 persons (2.8%), a greater incidence than estimated in meta-analyses of hospitalized cases with myocarditis (estimated incidence 0.0035%) after the second vaccination.”

Even after 30 days of observation, half of the group experiencing these negative effects still had higher levels of high-sensitivity cardiac troponin T, which indicates hidden heart damage.

Because there hasn’t been much research following people with heart injuries after messenger RNA vaccination, which is known to cause heart problems like myocarditis, the study’s long-term implications are not clear yet.

“According to current knowledge, the cardiac muscle can’t regenerate, or only to a very limited degree at best. So it’s possible that repeated booster vaccinations every year could cause moderate damage to the heart muscle cells,” said University Hospital Basel professor Christian Muller, a cardiologist and the study’s lead author, in a statement.

Within a month of getting the booster shot, none of the patients had a major heart problem like heart failure, and their heart readings on the electrocardiogram were normal.

The researchers suggested that those with higher levels of heart markers were told to avoid intense physical activity, which might have helped prevent more serious issues.

Despite cardiologists recommending heart scans for suspected vaccine-related heart inflammation, the participants didn’t undergo any imaging to check their hearts.

Dr. Andrew Bostom, a heart specialist in the United States who wasn’t part of the study, mentioned that if imaging had been done, it could have shown inflammation that leads to scarring or an irregular heartbeat.

The findings, according to Dr. Anish Koka, an American cardiologist, were “super useful to see how ‘cardioactive’ the booster is,” but it was difficult to assess how significant the higher troponin levels were, especially without a comparison to baseline levels. “There is really nothing clinically concerning at 30 days to report,” he tweeted.

Study Methods

The researchers suggested that more cases of vaccine-related heart damage could exist after messenger RNA booster shots than we initially thought. This could be due to people not showing noticeable symptoms or only having mild symptoms.

They defined “injury” as a significant rise in high-sensitivity cardiac troponin T three days after the vaccine, with no other apparent cause. The cardiac troponin levels had to reach a certain upper limit: 8.9 nanograms per liter for women and 15.5 nanograms per liter for men.

At the University Hospital Basel, all staff set to receive their first Moderna booster were invited to join the study unless they had a heart event or surgery within a month of getting vaccinated. The boosters, given from December 10, 2021, to February 10, 2022, were half the strength of the initial shots. The study involved 777 participants, including 540 women, with a median age of 37 years.

Out of the participants, 40 had higher levels of cardiac troponin. Among them, 18 had other reasons for this elevation. However, the researchers identified “vaccine-associated myocardial injury” in the remaining 22. This group had a median age of 46, and nearly all were women. This contrasts with most earlier research on vaccine-linked heart inflammation, which often affected more men. The researchers explained that this might be because women received a slightly larger vaccine dose per kilogram of body weight.

Baseline levels were not taken because the study should “interfere as little as possible with the motivation of the hospital staff to obtain the mRNA-1273 first booster vaccination and the logistics of booster vaccination itself,” according to the hospital’s COVID-19 task committee and the researchers.

None of the individuals with higher markers had a history of heart disease. While half had symptoms, most were non-specific, like a fever. Two participants experienced chest pain. According to the Brighton Collaboration case definition, two likely had myocarditis.

The choice to test high-sensitivity cardiac troponin T was due to its sensitivity.

“This marker is extremely sensitive—with other methods such as MRI, we wouldn’t have been able to detect any damage to the cardiac muscle, as it only becomes visible once the damage there is about three to five times greater,” Dr. Muller said.

The researchers couldn’t determine how the vaccine might harm the heart muscle.

The authors disclosed some potential conflicts of interest, including Dr. Muller’s grants from drug companies like Novartis and Roche. The University of Basel and the University Hospital Basel funded the study.

Limitations encompass the absence of initial levels and imaging.

Previous Findings, and Pending Study

Multiple other studies have investigated myocarditis cases after Pfizer vaccinations.

In Thailand, among 301 teenagers, 29 percent showed cardiovascular effects like chest pain after the second Pfizer shot. Seven of them were diagnosed with heart inflammation.

In Taiwan, researchers checked the initial electrocardiogram readings before the second Pfizer dose and found abnormal results in one percent of 4,928 primary school students after the shot. This group included five students diagnosed with myocarditis or irregular heartbeats.

An Israeli study followed 324 health care workers, mostly around 51 years old, who received a second Pfizer booster. Two cases of vaccine-related heart injury were identified on the third day.

Recent studies have also confirmed fatal cases of vaccine-induced myocarditis. A South Korean study investigated eight sudden deaths after mRNA vaccination, ruling out other possible causes. Researchers hadn’t suspected myocarditis as a reason for these deaths before conducting autopsies.

The Swiss researchers emphasized the need for more studies to investigate heart injuries after vaccination. They also highlighted that the long-term consequences of these injuries are not yet clear.

U.S. authorities mandated Moderna to carry out a study to examine the occurrence of subclinical myocarditis after a booster among adults. The study was expected to be finished by June 30, 2023. However, neither the U.S. Food and Drug Administration (FDA) nor Moderna have revealed the study results so far.

Pfizer was also required to conduct a similar study, with the results originally due by December 31, 2022. However, the FDA extended the deadline at Pfizer’s request.

Meanwhile, the US government has now invested nearly $6 billion in an effort led by President Biden to provide a lifeline to Moderna amid the COVID-19 crisis.

Read the document below

Biden Administration

The Biden Admin’s Attempt to Ban Cigarettes Just Days Before Trump Returns Setting Up For Boost in Criminal Cartels and Black Market

Published

on


Biden Administration’s Nicotine Ban: A Move Toward Regulation or a Boost for Cartels?

In a controversial move during its final days, the Biden administration is advancing a proposal to drastically lower nicotine levels in cigarettes, effectively banning traditional products on the market. While the administration frames the measure as a step toward reducing smoking addiction, critics argue it will backfire, fueling black markets and empowering criminal cartels.

Regulatory Shift with Broad Implications

The Food and Drug Administration (FDA) confirmed that its proposed rule to establish maximum nicotine levels in cigarettes has completed regulatory review. The measure is part of a broader effort to make cigarettes less addictive, potentially shaping one of the most impactful tobacco policies in U.S. history.

FDA Commissioner Robert Califf previously stated that the initiative aims to “decrease the likelihood that future generations of young people become addicted to cigarettes and help more currently addicted smokers to quit.” However, opponents warn that this policy could create new public safety and economic challenges.

A “Gift” to Organized Crime

Critics of the proposed regulation, including former ATF official Rich Marianos, are sounding the alarm. Marianos described the plan as a “gift with a bow and balloons to organized crime cartels,” arguing that it would open the floodgates for illegal tobacco trafficking.

Mexican cartels, Chinese counterfeiters, and Russian mafias are well-positioned to exploit the demand for high-nicotine cigarettes. These groups, already entrenched in smuggling operations, would likely ramp up efforts to meet consumer demand. This shift would not only enrich organized crime but also compromise public health by introducing unregulated, potentially more harmful products into the market.

Unintended Consequences for Public Health

While the FDA’s goal is to reduce smoking rates, experts suggest the policy may have the opposite effect. Smokers could resort to “compensatory smoking,” consuming more cigarettes to achieve their desired nicotine levels. This behavior increases exposure to harmful chemicals like tar, negating the intended health benefits.

Additionally, the regulation could discourage smokers from transitioning to safer alternatives, such as vaping or nicotine replacement therapies. By removing higher-nicotine products from the legal market, the government risks alienating individuals who might otherwise seek healthier pathways to quitting smoking.

National Security and Economic Concerns

Beyond health implications, the nicotine ban raises significant national security issues. A 2015 State Department report highlighted the role of tobacco trafficking in funding terrorist organizations and criminal networks. Reducing nicotine levels in cigarettes could expand this illicit market, providing criminal groups with a lucrative new revenue stream.

Moreover, law enforcement agencies could face increased pressure as they work to combat tobacco smuggling alongside ongoing efforts to address opioid and fentanyl trafficking. This strain on resources could compromise broader public safety initiatives.

Balancing Public Health and Freedom

The proposed nicotine reduction also ignites debates over personal freedom. While reducing addiction is a laudable goal, critics argue that adults should retain the right to make their own choices regarding tobacco use. For many, the measure feels like government overreach, imposing a paternalistic approach to health regulation.

As the Biden administration pushes forward with its nicotine reduction proposal, the policy’s broader implications remain uncertain. While intended to curb addiction and promote public health, critics warn of significant risks, including empowering organized crime, increasing smoking rates, and straining law enforcement resources.

A more balanced approach—focused on education, harm reduction, and access to cessation resources—may better address smoking-related challenges without creating new societal harms.


Continue Reading

Trending

McDonald’s to Scrap DEI Practices

Published

on

McDonald’s has announced plans to scale back certain diversity, equity, and inclusion (DEI) initiatives, citing a “shifting legal landscape” following the U.S. Supreme Court’s 2023 decision to end affirmative action in college admissions.

The fast-food corporation intends to retire specific diversity goals for senior leadership positions and discontinue a program that encouraged suppliers to implement diversity training and enhance minority representation within their leadership teams. Additionally, McDonald’s will pause participation in external surveys that assess workplace inclusion, a move similar to recent actions by companies like Lowe’s and Ford Motor Co.

Despite these changes, McDonald’s emphasizes its ongoing commitment to fostering an inclusive environment. The company reports that 30% of its U.S. leaders come from underrepresented groups and that it has achieved gender pay equity across all levels since setting that goal in 2021. McDonald’s also plans to continue supporting efforts to maintain a diverse base of employees, suppliers, and franchisees, and will keep reporting its demographic information.

This development aligns with a broader trend among major corporations reassessing their DEI strategies in response to legal and societal shifts. Companies such as Walmart, John Deere, and Harley-Davidson have similarly rolled back diversity programs following the Supreme Court’s ruling and subsequent conservative backlash.

Continue Reading

Trending

Tesla Accused of Replacing Thousands of Laid-off U.S. Workers With Foreign Employees on H-1B Visas

Published

on

Reports have surfaced alleging that Tesla replaced thousands of laid-off U.S. workers with foreign employees on H-1B visas, prompting scrutiny of the company’s hiring practices and raising questions about broader labor policies. This controversy gained traction following Tesla’s April 2024 layoffs of approximately 15,000 employees, particularly in Texas and California, and the company’s subsequent requests for over 2,000 H-1B visas—more than three percent of the total available nationwide.

The H-1B visa program allows U.S. companies to hire foreign workers for specialized roles when there is a shortage of qualified domestic candidates. However, critics argue that the program is sometimes exploited to replace higher-paid American workers with lower-cost foreign labor. In Tesla’s case, some former employees have claimed that senior engineers were replaced by younger, less experienced foreign engineers at significantly lower salaries.

This has sparked concerns about potential misuse of the H-1B program, with critics alleging that companies like Tesla may be prioritizing cost-cutting measures over the retention of skilled U.S. workers.

Tesla CEO Elon Musk, who is an immigrant and has benefitted from U.S. visa programs, has been an outspoken defender of the H-1B program. In a recent post on his social media platform, X, Musk sharply responded to critics calling for reforms to the program. He emphasized the importance of H-1B visas in attracting talented individuals who have contributed to the growth of companies like SpaceX and Tesla, which he argued have played a significant role in strengthening the U.S. economy. Musk’s comment, quoting a line from the film Tropic Thunder

, sparked a wide range of reactions, further polarizing opinions on the issue.

Supporters of the H-1B program, including Musk and entrepreneur Vivek Ramaswamy, argue that the U.S. faces a shortage of skilled workers, especially in STEM fields, and that foreign talent is essential for innovation and economic progress. They contend that the H-1B program helps fill these gaps and sustains U.S. competitiveness on the global stage.

On the other hand, critics, particularly from conservative groups, argue that the program is often misused to displace American workers and should be reformed to ensure it is used for its intended purpose—addressing real talent shortages rather than cutting labor costs.

The Tesla situation adds to the broader debate over immigration and labor policies in the U.S. As the discourse continues to intensify, Tesla’s use of the H-1B program may serve as a focal point in discussions about labor policy and its impact on American workers, particularly in the technology sector.

SOURCE: ELECTREK

Continue Reading

Trending